Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported financial results for the first quarter ended March 31, 2013.
Revenues for the quarter ending March 31, 2013 were $11.1 million compared with $2.2 million during the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
